Tartrate-resistant acid phosphatase 5b as a serum marker of bone metastasis in breast cancer patients.

J Biomed Sci 2004 Jul-Aug;11(4):511-6

Division of Hematology/Oncology, Department of Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, ROC.

Diagnosis and follow-up of bone metastases in breast cancer patients usually rely on symptoms and imaging studies. Tartrate-resistant acid phosphatase 5b (TRACP 5b) is a specific marker of osteoclasts and is herein proposed as a marker of bone metastasis in breast cancer patients. An immunoassay using a monoclonal antibody, 14G6, was used to measure the activity of serum TRACP 5b at pH 6.1 in 30 early breast cancer patients without bone metastasis and in 30 aged-matched breast cancer patients with bone metastasis. Another 60 normal volunteers were recruited as controls. Bone alkaline phosphatase (BAP), a traditional marker of bone turnover, was also measured in selected cases. The overall mean TRACP 5b activity in normal women was 2.83 +/- 1.1 U/l, and it increased with age. The mean TRACP 5b activity in early breast cancer patients did not differ from that of the normal group (2.93 +/- 0.64 vs. 2.83 +/- 1.1 U/l; p = 0.66), whereas it was significantly higher in breast cancer patients with bone metastasis (5.42 +/- 2.5 vs. 2.83 +/- 1.1 U/l; p < 0.0001). BAP activity was significantly higher in breast cancer patients with bone metastasis than in early breast cancer patients (p = 0.004). Serum TRACP 5b activity correlated well with BAP activity in breast cancer patients with bone metastasis (p < 0.0001), but not in normal individuals or in patients without bone metastasis. TRACP 5b activity can be considered a surrogate indicator of bone metastasis in breast cancer patients.

Download full-text PDF

Source
http://dx.doi.org/10.1007/bf02256100DOI Listing
March 2005
1 Read

Publication Analysis

Top Keywords

breast cancer
44
cancer patients
44
bone metastasis
36
patients bone
24
tracp activity
16
early breast
12
+/- u/l
12
283 +/-
12
metastasis breast
12
patients
12
bone
12
marker bone
12
breast
11
cancer
11
metastasis
9
serum tracp
8
tartrate-resistant acid
8
higher breast
8
acid phosphatase
8
bap activity
8

References

(Supplied by CrossRef)

SH Cheng et al.
Breast Cancer Res Treat 2000

B Fisher et al.
Ann Surg 1968

JM Halleen et al.
J Bone Miner Res 2000

JM Halleen et al.
Clin Chem 2001

J Halleen et al.
J Bone Miner Res 1996

R Hannon et al.
J Bone Miner Res 1998

BE Hillner et al.
J Clin Oncol 2000

AJ Janckila et al.
Clin Chem 2001

KW Lam et al.
Prog Clin Biol Res 1982

KW Lam et al.
Clin Chem 1978

KW Lam et al.
Clin Chem 1981

Similar Publications